Effects of the potassium ion channel modulators BMS-204352 Maxipost and its R-enantiomer on salicylate-induced tinnitus in rats

Physiology and Behavior

Volumn 104, Issue 5, 2011, Pages 873-879

  Lobarinas, Edward ^a   Dalby Brown, William ^b   Stolzberg, Daniel ^a   Mirza, Naheed R ^b   Allman, Brian L ^a   Salvi, Richard ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NEUROSEARCH A S   (Denmark)

Author keywords

BK; Conditioning; K Ca1.1; K v7; KCNQ; Rats; Salicylate; Schedule induced polydipsia; Tinnitus

Indexed keywords

ANXIOLYTIC AGENT; FLINDOKALNER; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KCNQ2; R MAXIPOST; SALICYLATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; AUDITORY NERVOUS SYSTEM; DRINKING; DRUG INHIBITION; ENANTIOMER; MALE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SOUND; SPRAGUE DAWLEY RAT; TINNITUS;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INDOLES; MALE; POLYSORBATES; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; SALICYLATES; SURFACE-ACTIVE AGENTS; TINNITUS;

EID: 80053053909     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.05.022     Document Type: Article

References (46)

1. Wang Q., et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996, 12(1):17-23.
2. Demeester K., et al. Prevalence of tinnitus and audiometric shape. B-ENT 2007, 3(Suppl 7):37-49.
3. Hannaford P.C., et al. The prevalence of ear, nose and throat problems in the community: results from a national cross-sectional postal survey in Scotland. Fam Pract 2005, 22(3):227-233.
4. Coles R.R. Epidemiology of tinnitus: (1) prevalence. J Laryngol Otol Suppl 1984, 9:7-15.
5. McCombe A., et al. Guidelines for the grading of tinnitus severity: the results of a working group commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons, 1999. Clin Otolaryngol Allied Sci 2001, 26(5):388-393.
6. Dobie R.A. A review of randomized clinical trials in tinnitus. Laryngoscope 1999, 109(8):1202-1211.
7. Dobie R.A. Clinical trials and drug therapy for tinnitus. Tinnitus: Theory and Management 2004, 266-277. BC Decker, Inc, Hamilton. J.B.J. Snow (Ed.).
8. Robinson S., Viirre E.S., Stein M.B. Antidepressant therapy for tinnitus. Tinnitus: Theory and Management 2004, 278-293. BC Decker, Inc, Hamilton. J.B.J. Snow (Ed.).
9. Smith P.F., Darlington C.L. Drug treatments for subjective tinnitus: serendipitous discovery versus rational drug design. Curr Opin Investig Drugs 2005, 6(7):712-716.
10. Salvi R., Lobarinas E., Sun W. Pharmacological treatments for tinnitus: new and old. Drugs Future 2009, 34(5):381-400.
11. Lobarinas E., et al. A novel behavioral paradigm for assessing tinnitus using schedule-induced polydipsia avoidance conditioning (SIP-AC). Hear Res 2004, 190(1-2):109-114.
12. Korsgaard M.P., et al. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. J Pharmacol Exp Ther 2005, 314(1):282-292.
13. Caminos E., et al. The potassium channel KCNQ5/Kv7.5 is localized in synaptic endings of auditory brainstem nuclei of the rat. J Comp Neurol 2007, 505(4):363-378.
14. Navarro-Lopez J., et al. Electrophysiological and molecular analysis of Kv7/KCNQ potassium channels in the inferior colliculus of adult guinea pig. J Mol Neurosci 2009, 37(3):263-268.
15. Brozoski T.J., Spires T.J., Bauer C.A. Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. J Assoc Res Otolaryngol 2007, 8(1):105-118.
16. Eggermont J.J., Roberts L.E. The neuroscience of tinnitus. Trends Neurosci 2004, 27(11):676-682.
17. Gribkoff V.K. The therapeutic potential of neuronal KCNQ channel modulators. Expert Opin Ther Targets 2003, 7(6):737-748.
18. Maljevic S., Wuttke T.V., Lerche H. Nervous system KV7 disorders: breakdown of a subthreshold brake. J Physiol 2008, 586(7):1791-1801.
19. Maljevic S., et al. KV7 channelopathies. Pflugers Arch 2010, 460(2):277-288.
20. Jastreboff P.J., et al. Phantom auditory sensation in rats: an animal model for tinnitus. Behav Neurosci 1988, 102(6):811-822.
21. Guitton M.J., et al. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci 2003, 23(9):3944-3952.
22. Kiang N.Y.S., Moxon E.C., Levine R.A. Auditory-nerve activity in cats with normal and abnormal cochleas. Sensorineural Hearing Loss 1970, 241-273. J & A Churchill, London. G.E.W. Wolstenholme, J. Knight (Eds.).
23. Wang J., et al. Effects of selective inner hair cell loss on auditory nerve fiber threshold, tuning and spontaneous and driven discharge rate. Hear Res 1997, 107(1-2):67-82.
24. Evans E.F., Borerwe T.A. Ototoxic effects of salicylate on the response of single cochlear nerve fibers and on cochlear potentials. Br J Audiol 1982, 16:101-108.
25. Kumagai M. Effect of intravenous injection of aspirin on the cochlea. Hokkaido Igaku Zasshi 1992, 67(2):216-233.
26. Stypulkowski P.H. Mechanisms of salicylate ototoxicity. Hear Res 1990, 46(1-2):113-145.
27. Muller M., et al. Auditory nerve fibre responses to salicylate revisited. Hear Res 2003, 183(1-2):37-43.
28. Ma W.L., Hidaka H., May B.J. Spontaneous activity in the inferior colliculus of CBA/J mice after manipulations that induce tinnitus. Hear Res 2006, 212(1-2):9-21.
29. Yang G., et al. Salicylate induced tinnitus: behavioral measures and neural activity in auditory cortex of awake rats. Hear Res 2007, 226(1-2):244-253.
30. Knipper M., et al. Deafness in LIMP2-deficient mice due to early loss of the potassium channel KCNQ1/KCNE1 in marginal cells of the stria vascularis. J Physiol 2006, 576(Pt 1):73-86.
31. Liang G.H., et al. Molecular analyses of KCNQ1-5 potassium channel mRNAs in rat and guinea pig inner ears: expression, cloning, and alternative splicing. Acta Otolaryngol 2006, 126(4):346-352.
32. Goldman A.M., et al. Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death. Sci Transl Med 2009, 1(2):2ra6.
33. Jin Z., et al. Expression and localization of K channels KCNQ2 and KCNQ3 in the mammalian cochlea. Audiol Neurootol 2009, 14(2):98-105.
34. Robbins J. KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther 2001, 90(1):1-19.
35. Hewawasam P., et al. The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channels. Bioorg Med Chem Lett 2002, 12(7):1023-1026.
36. Miller C. An overview of the potassium channel family. Genome Biol 2000, 1(4). p. REVIEWS0004.
37. Marcotti W., Johnson S.L., Kros C.J. Effects of intracellular stores and extracellular Ca(2+) on Ca(2+)-activated K(+) currents in mature mouse inner hair cells. J Physiol 2004, 557(Pt 2):613-633.
38. Kros C.J. How to build an inner hair cell: challenges for regeneration. Hear Res 2007, 227(1-2):3-10.
39. Hafidi A., Beurg M., Dulon D. Localization and developmental expression of BK channels in mammalian cochlear hair cells. Neuroscience 2005, 130(2):475-484.
40. Shen Z., et al. BK channels mediate the voltage-dependent outward current in type I spiral ligament fibrocytes. Hear Res 2004, 187(1-2):35-43.
41. + channels to auditory neurotransmission in the Guinea pig cochlea. J Neurophysiol 2003, 90(1):320-332.
42. Kim Y., Trussell L.O. Ion channels generating complex spikes in cartwheel cells of the dorsal cochlear nucleus. J Neurophysiol 2007, 97(2):1705-1725.
43. N'Gouemo P., Yasuda R.P., Faingold C.L. Protein expression of small conductance calcium-activated potassium channels is altered in inferior colliculus neurons of the genetically epilepsy-prone rat. Brain Res 2009, 1270:107-111.
44. + channels of the BK-type in the mouse brain. Histochem Cell Biol 2006, 125(6):725-741.
45. Brozoski T.J., Spires T.J., Bauer C.A. Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. J Assoc Res Otolaryngol 2007.
46. Nardi A., Olesen S.P. BK channel modulators: a comprehensive overview. Curr Med Chem 2008, 15(11):1126-1146.